PFE | tickerfilter.com

Fundamental analysis

43%

Profitability 39%

Dept financing 26%

Liquidity 63%

Performance 45%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.90%

1 Month

0.27%

3 Months

1.39%

6 Months

-14.87%

1 Year

-8.99%

2 Year

-35.84%

Key data

Stock price

$25.60

P/E Ratio

18.42

DAY RANGE

$25.53 - $26.07

EPS

$1.58

52 WEEK RANGE

$24.48 - $31.54

52 WEEK CHANGE

-$8.38

MARKET CAP

147.900 B

YIELD

6.44%

SHARES OUTSTANDING

5.667 B

DIVIDEND

$0.43

EX-DIVIDEND DATE

01-24-2025

NEXT EARNINGS DATE

N/A

BETA

0.06

PUBLIC FLOAT

AVERAGE 10 VOLUME

$45,178,937

AVERAGE 30 VOLUME

$41,800,390

Company detail

CEO: Albert Bourla
Region: US
Website: pfizer.com
Employees: 83,000
IPO year: 1972

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health. The company also provides biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Cibinqo brands.

PFE - PFIZER INC